Managing inhaled anesthesia: Challenges from a health-system pharmacist's perspective

American Journal of Health-System Pharmacy

Volumn 67, Issue 8 SUPPL. 4, 2010, Pages

  Meyer, Tricia ^a,b,c  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

^c Texas A and M Medical School   (United States)

Author keywords

Anesthetics; Costs; Desflurane; Drug administration; Hospitals; Isoflurane; Pharmaceutical services; Pharmacists, hospital; Pharmacy, institutional, hospital; Sevoflurane; Solubility; Surgery; Toxicity

Indexed keywords

DESFLURANE; INHALATION ANESTHETIC AGENT; ISOFLURANE; SEVOFLURANE; DRUG DERIVATIVE; ETHER DERIVATIVE;

ANESTHESIA INDUCTION; CLINICAL PRACTICE; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DRUG DELIVERY SYSTEM; DRUG MARKETING; DRUG SOLUBILITY; DRUG USE; FLOW RATE; HEALTH CARE; HEALTH CARE COST; HUMAN; INHALATION ANESTHESIA; OPERATING ROOM; PHARMACIST; PRIORITY JOURNAL; TREATMENT INDICATION; UNITED STATES; APPARATUS, EQUIPMENT AND SUPPLIES; ARTICLE; DRUG UTILIZATION; ECONOMICS; HOSPITAL PHARMACY; ORGANIZATION AND MANAGEMENT;

ANESTHETICS, INHALATION; DRUG UTILIZATION; EQUIPMENT AND SUPPLIES; HUMANS; ISOFLURANE; METHYL ETHERS; OPERATING ROOMS; PHARMACY SERVICE, HOSPITAL;

EID: 77954683953     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp100092     Document Type: Conference Paper

References (16)

1. Smith I. Cost considerations in the use of anaesthetic drugs. Pharmacoeconomics. 2001; 19(5 Pt 1):469-81. (Pubitemid 32488749)
2. Chernin E. Pharmacoeconomics of inhaled anesthetic agents: considerations for the pharmacist. Am J Health-Syst Pharm. 2004; 61(Suppl 4):S18-22.
3. Odin I, Feiss P. Low flow and economics of inhalational anaesthesia. Best Pract Res Clin Anaesthesiol. 2005; 19:399-413. (Pubitemid 40753808)
4. Stachnik J. Inhaled anesthetic agents. Am J Health-Syst Pharm. 2006; 63:623-34.
5. Eger EI II. Characteristics of anesthetic agents used for induction and maintenance of general anesthesia. Am J Health-Syst Pharm. 2004; 61(Suppl 4):S3-10.
6. TerRiet MF, DeSouza GJ, Jacobs JS et al. Which is most pungent: isoflurane, sevoflurane or desflurane? Br J Anaesth. 2000; 85:305-7.
7. Eger EI, White PF, Bogetz MS. Clinical and economic factors important to anaesthetic choice for day-case surgery. Pharmacoeconomics. 2000; 17:245-62. (Pubitemid 30214632)
8. Zhou JX, Liu J. The effect of temperature on solubility of volatile anesthetics in human tissues. Anesth Analg. 2001; 93:234-8. (Pubitemid 32601187)
9. Ultane package insert. North Chicago, IL: Abbott Laboratories; 2009 Jul.
10. Morgan GE, Mikhail MS, Murray MJ. Inhalation anesthetics. In: Clinical anesthesiology. 4th ed. New York: Lange Medical; 2005: Chapter 7.
11. Dikmen Y, Eminoglu E, Salihoglu Z et al. Pulmonary mechanics during isoflurane, sevoflurane and desflurane anaesthesia. Anaesthesia. 2003; 58:745-8. (Pubitemid 36934566)
12. Fee JP, Thompson GH. Comparative tolerability profiles of the inhaled anaesthetics. Drug Saf. 1997; 16:157-70. (Pubitemid 27145963)
13. Bailey JM. Context-sensitive half-times and other decrement times of inhaled anesthetics. Anesth Analg. 1997; 85:681-6. (Pubitemid 27381329)
14. Suttner S, Boldt J. Low-flow anaesthesia. Does it have potential pharmacoeconomic consequences? Pharmacoeconomics. 2000; 17:585-90.
15. Golembiewski J. Considerations in selecting an inhaled anesthetic agent: case studies. Am J Health-Syst Pharm. 2004; 61(Suppl 4):S10-7.
16. McGrath B, Chung F. Postoperative recovery and discharge. Anesthesiol Clin North Am. 2003; 21:367-86. (Pubitemid 36702433)